Evidence map›Paper›PMID 26148697›Full record

ArticleScientific reports2015

A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells.

Martin Müller, Jana Schröer, Ninel Azoitei, Tim Eiseler, Wendy Bergmann, Ralf Köhntop, Qiong Lin, Ivan G Costa, Martin Zenke, Felicitas Genze and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Protein kinase D signaling in cancer: A friend or foe?Biochimica et biophysica acta. Reviews on cancer · 2017
    Review
  4. Review
  5. Pluripotency Factors on Their Lineage Move.Stem cells international · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Martin MüllerDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Jana SchröerDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Ninel AzoiteiDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Tim EiselerDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Wendy BergmannDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Ralf KöhntopDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Qiong LinDepartment of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.
Ivan G CostaIZKF Computational Biology Research Group, RWTH Aachen University Medical School, Aachen, Germany.
Martin ZenkeDepartment of Cell Biology, Institute for Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.
Felicitas GenzeDepartment of Urology, Ulm University, Ulm, Germany.
Clair WeidgangDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Thomas SeufferleinDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Stefan LiebauInstitute of Neuroanatomy, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Alexander KlegerDepartment of Internal Medicine I, Ulm University, Ulm, Germany.
Universität Ulm · DERWTH Aachen University · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protein kinase D isoenzymes PKD1/2/3 are prominent downstream targets of PKCs (Protein Kinase Cs) and phospholipase D in various biological systems. Recently, we identified PKD isoforms as novel mediators of tumour cell-endothelial cell communication, tumour cell motility and metastasis. Although PKD isoforms have been implicated in physiological/tumour angiogenesis, a role of PKDs during embryonic development, vasculogenesis and angiogenesis still remains elusive. We investigated the role of PKDs in germ layer segregation and subsequent vasculogenesis and angiogenesis using mouse embryonic stem cells (ESCs). We show that mouse ESCs predominantly express PKD2 followed by PKD3 while PKD1 displays negligible levels. Furthermore, we demonstrate that PKD2 is specifically phosphorylated/activated at the time of germ layer segregation. Time-restricted PKD2-activation limits mesendoderm formation and subsequent cardiovasculogenesis during early differentiation while leading to branching angiogenesis during late differentiation. In line, PKD2 loss-of-function analyses showed induction of mesendodermal differentiation in expense of the neuroectodermal germ layer. Our in vivo findings demonstrate that embryoid bodies transplanted on chicken chorioallantoic membrane induced an angiogenic response indicating that timed overexpression of PKD2 from day 4 onwards leads to augmented angiogenesis in differentiating ESCs. Taken together, our results describe novel and time-dependent facets of PKD2 during early cell fate determination.

Indexed as

AnimalsCell DifferentiationCell LineChickensChorioallantoic MembraneDoxycyclineEmbryoid BodiesGene Knock-In TechniquesImmunohistochemistryInduced Pluripotent Stem CellsMiceMice, Inbred C57BLMouse Embryonic Stem CellsNeovascularization, PathologicProtein Kinase CProtein Kinase D2DoxycyclineProtein Kinase Cprotein kinase C nuprotein kinase DProtein Kinase D2Protein Kinases

Identifiers

PMID26148697
PMCPMC4493579
OpenAlexW844523808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.